The University of Chicago Header Logo

Stanley Liauw

TitleProfessor
InstitutionUniversity of Chicago
DepartmentRadiation and Cellular Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Stanley Liauw serves as the Director of Clinical Operations and is the clinical lead for the genitourinary (GU) cancer program and the gastrointestinal (GI) cancer program within the Department of Radiation and Cellular Oncology at the University of Chicago. In the past 10 years on faculty, Dr. Liauw has developed research programs in these disease sites, with an interest in outcomes research and clinical trials. The central mission of his research is to conduct clinical studies to define current clinical outcomes and areas of need, develop hypotheses, and test novel regimens to reduce the morbidity or mortality of radiation therapy in the treatment of cancer.

    A major focus of Dr. Liauw's efforts include the periodic analysis and reporting of cancer outcomes with radiation therapy. This work, derived from multiple institutional databases of more than 2000 patients, has resulted in numerous abstract presentations and publications in peer-reviewed journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology, Biology, Physics and Cancer. These contributions generally fall into 3 categories of interest: presenting hypotheses to improve the therapeutic ratio of therapy, studying the use of imaging in radiation oncology, and exploring potential markers of response to therapy.

    A number of clinical protocols have been opened for patients with genitourinary and gastrointestinal cancers. Dr. Liauw has investigated and initiated trials for a: phase I study of dose escalated stereotactic body RT trial for unresectable pancreatic cancer, phase II quality of life study of oral hormonal therapy with RT for prostate cancer, phase I study for oligometastatic renal cell cancer, and phase I randomized study for hepatocellular carcinoma treated with RT and immunotherapy.

    Outside of his research interests, Dr. Liauw has overseen several intradepartmental projects aimed at improving clinical workflow and patient safety, with potential downstream effects on patient and employee satisfaction. He served as the clinical lead for the implementation of intraoperative radiation therapy in 2015, as an Associate Editor for GI cancers for the International Journal of Radiation Oncology, Biology, and Physics, as an examiner and question writer for the American Board of Radiology for GU cancers, and an invited speaker for national and international educational lectures such as through the American Society of Radiation Oncology (ASTRO) and the American Urological Association. He has been an invited Visiting Professor for resident education at multiple institutions, and has been regularly recognized from the University of Chicago training program as a top educator. He has been an ad hoc reviewer of manuscripts for more than 20 scientific journals, including Journal of Clinical Oncology and the New England Journal of Medicine.

    Collapse Biography 
    Collapse education and training
    MIT, Cambridge, MABS6/1997Chemical Engineering
    UT Southwestern Medical School, Dallas, TXMD6/2001Medicine
    Brigham and Women's Hospital, Boston, MAInternship6/2002Internal Medicine
    University of Florida, Gainesville, FLResidency6/2006Radiation Oncology

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lynch C, Sweis RF, Modi P, Agarwal PK, Szmulewitz RZ, Stadler WM, O'Donnell PH, Liauw SL, Pitroda SP. Bladder-Preserving Trimodality Therapy With Capecitabine. Clin Genitourin Cancer. 2024 04; 22(2):476-482.e1. PMID: 38228414.
      Citations:    Fields:    Translation:Humans
    2. Liauw SL, Pitroda SP. Multidisciplinary Collaboration is Key. Int J Radiat Oncol Biol Phys. 2023 Dec 01; 117(5):1047-1048. PMID: 37980133.
      Citations:    Fields:    Translation:Humans
    3. Shimomura A, Wu T, Rusu I, Kishan AU, Tree AC, Solanki AA, Liauw SL, Shimomura A, Wu T, Rusu I, Kishan AU, Solanki AA, Liauw SL. Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):146-153. PMID: 37875222.
      Citations:    Fields:    Translation:Humans
    4. Patel M, Turchan WT, Morris CG, Augustine D, Wu T, Oto A, Zagaja GP, Liauw SL. A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life. Cancers (Basel). 2023 Feb 20; 15(4). PMID: 36831677; PMCID: PMC9953871.
      Citations: 2     
    5. Venkatesulu B, Liauw SL, Joshi M, Baumann BC, Yoo R, Choudhury A, Efstathiou JA, Murthy V, Solanki AA, Roupret M, Sargos P. Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder Cancer. Semin Radiat Oncol. 2023 Jan; 33(1):35-50. PMID: 36517192.
      Citations:    Fields:    
    6. Arshad M, Al-Hallaq H, Polite BN, Shogan BD, Hyman N, Liauw SL. ASO Visual Abstract: Intraoperative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry. Ann Surg Oncol. 2023 Jan; 30(1):333-334. PMID: 36224512.
      Citations:    Fields:    
    7. Dhiman A, Vining CC, Witmer HDD, Sood D, Shergill A, Kindler H, Roggin KK, Posner MC, Ahmed OS, Liauw S, Pitroda S, Liao CY, Karrison T, Weichselbaum R, Eng OS, Catenacci DVT, Turaga KK, Polite B. ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 Dec; 29(Suppl 3):616-617. PMID: 35930113.
      Citations: 1     Fields:    Translation:CTClinical Trials
    8. Tran PT, Lowe K, Tsai HL, Song DY, Hung AY, Hearn JWD, Miller S, Proudfoot JA, Deek MP, Phillips R, Lotan T, Paller CJ, Marshall CH, Markowski M, Dipasquale S, Denmeade S, Carducci M, Eisenberger M, DeWeese TL, Orton M, Deville C, Davicioni E, Liauw SL, Heath EI, Greco S, Desai NB, Spratt DE, Feng F, Wang H, Beer TM, Antonarakis ES. Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial. J Clin Oncol. 2023 02 20; 41(6):1307-1317. PMID: 36367998; PMCID: PMC9940936.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    9. Arshad M, Al-Hallaq H, Polite BN, Shogan BD, Hyman N, Liauw SL. Intra-operative Radiation Therapy for Colorectal or Anal Cancer at Risk for Margin-Positive Resection: Initial Results of a Single-Institution Registry. Ann Surg Oncol. 2022 Oct 18. PMID: 36255512.
      Citations:    Fields:    
    10. Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL. Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):202-213. PMID: 36108891.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    11. Andolfi C, Vickers AJ, Cooperberg MR, Carroll PR, Cowan JE, Paner GP, Helfand BT, Liauw SL, Eggener SE. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue. Urology. 2022 12; 170:154-160. PMID: 35987380; PMCID: PMC10515713.
      Citations: 1     Fields:    Translation:Humans
    12. Turchan WT, Cutright D, Wu T, Leng JX, Dignam JJ, Eggener SE, Liauw SL. Reply by Authors. J Urol. 2022 06; 207(6):1245. PMID: 35236091.
      Citations:    Fields:    
    13. Turchan WT, Cutright D, Wu T, Leng JX, Dignam JJ, Eggener SE, Liauw SL. Hematuria following Post-Prostatectomy Radiotherapy: Incidence Increases with Long-Term Followup. J Urol. 2022 06; 207(6):1236-1245. PMID: 35050703.
      Citations: 1     Fields:    Translation:Humans
    14. Dhiman A, Vining CC, Witmer HDD, Sood D, Shergill A, Kindler H, Roggin KK, Posner MC, Ahmed OS, Liauw S, Pitroda S, Liao CY, Karrison T, Weichselbaum R, Polite B, Eng OS, Catenacci DVT, Turaga KK. Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels. Ann Surg Oncol. 2022 Jan 05. PMID: 34988836; PMCID: PMC8730296.
      Citations:    Fields:    
    15. Willett GCECG, Chang DT, Czito BG, Liauw SL, Wo JY, Klein PEE, Chen Z, Carlson DJ, Chetty IJ. Reflections on Anthony Zietman From Gastrointestinal Cancer and Physics Editors. Int J Radiat Oncol Biol Phys. 2021 Dec 01; 111(5):1114-1117. PMID: 34793734.
      Citations:    Fields:    Translation:Humans
    16. Liauw SL, Son CH, Shergill A, Shogan BD. Circulating tumor-tissue modified HPV DNA analysis for molecular disease monitoring after chemoradiation for anal squamous cell carcinoma: a case report. J Gastrointest Oncol. 2021 Dec; 12(6):3155-3162. PMID: 35070439; PMCID: PMC8748062.
      Citations: 1     
    17. Arshad M, Al-Hallaq HA, Polite BN, Hyman N, Liauw S. Intra-Operative Radiation Therapy and Surgical Excision for Locally Recurrent Gastrointestinal Cancers: Initial Results of a Single-Institution Registry. Int J Radiat Oncol Biol Phys. 2021 Nov 01; 111(3S):e28-e29. PMID: 34701081.
      Citations:    
    18. Turchan WT, Cutright D, Wu T, Leng JX, Eggener S, Liauw S. Incidence and Severity of Hematuria After Post-Prostatectomy Radiotherapy in a Cohort With Long-Term Follow-up. Int J Radiat Oncol Biol Phys. 2021 Nov 01; 111(3S):e296. PMID: 34701117.
      Citations:    
    19. Chatterjee A, Turchan WT, Fan X, Griffin A, Yousuf A, Karczmar GS, Liauw SL, Oto A. Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer? Acad Radiol. 2022 07; 29(7):977-985. PMID: 34645572.
      Citations: 3     Fields:    Translation:Humans
    20. Tward J, Lenz L, Flake DD, Rajamani S, Yonover P, Olsson C, Kapoor DA, Mantz C, Liauw SL, Antic T, Fabrizio M, Salzstein D, Shore N, Albertson D, Henderson J, Lee SP, Gay HA, Michalski J, Hung A, Raben D, Garraway I, Lewis MS, Nguyen PL, Marshall DT, Brawer MK, Stone S, Cohen T. The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation. Int J Radiat Oncol Biol Phys. 2022 05 01; 113(1):66-76. PMID: 34610388.
      Citations: 3     Fields:    Translation:Humans
    21. Turchan WT, Liauw SL. Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV Status. Semin Radiat Oncol. 2021 10; 31(4):349-360. PMID: 34455990.
      Citations: 3     Fields:    Translation:Humans
    22. Liauw SL. High-risk Prostate Cancer Treated with Radiation Therapy: Opportunities to Reduce Cancer Mortality after Biochemical Failure. Eur Urol. 2021 08; 80(2):147-148. PMID: 34053781.
      Citations:    Fields:    Translation:Humans
    23. Hong D, Das LC, Daily E, Levine SK, Hahn OM, Liauw SL, Golden DW, Son CH. Goals of care discussions: perceptions of radiation and medical oncologists. Support Care Cancer. 2021 Dec; 29(12):7279-7288. PMID: 34031753.
      Citations: 2     Fields:    Translation:Humans
    24. Onderdonk BE, Dorn PL, Martinez C, Arif F, Cloutier D, Antic T, Golden DW, Karrison T, Pitroda SP, Szmulewitz RZ, Liauw SL. A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity. Cancer. 2021 08 01; 127(15):2631-2640. PMID: 33882144.
      Citations: 2     Fields:    Translation:HumansCells
    25. Brower JV, Chen S, Ritter A, Liauw SL, Rosenberg SA, Reddy AV, Golden DW, Gillespie EF, Mattes MD. Comfort Level of US Radiation Oncology Graduates: Assessment of Transition to Independent Clinical Practice. J Cancer Educ. 2021 04; 36(2):278-283. PMID: 31728920; PMCID: PMC7441593.
      Citations: 2     Fields:    Translation:Humans
    26. Liauw SL, Ni L, Wu T, Arif F, Cloutier D, Posner MC, Kozloff M, Kindler HL. A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses. J Gastrointest Oncol. 2020 Dec; 11(6):1399-1407. PMID: 33457009; PMCID: PMC7807259.
      Citations: 5     
    27. Dinh TT, Mitin T, Bagshaw HP, Hoffman KE, Hwang C, Jeffrey Karnes R, Kishan AU, Liauw SL, Lloyd S, Potters L, Showalter TN, Taira AV, Vapiwala N, Zaorsky NG, D'Amico AV, Nguyen PL, Davis BJ. Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer. Int J Radiat Oncol Biol Phys. 2021 03 15; 109(4):953-963. PMID: 33127490.
      Citations: 3     Fields:    Translation:Humans
    28. Turchan WT, Gutiontov SI, Spiotto MT, Liauw SL. Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication Allergies. JNCI Cancer Spectr. 2020 Dec; 4(6):pkaa081. PMID: 33409456; PMCID: PMC7771007.
      Citations:    Fields:    
    29. Liauw SL, Ham SA, Das LC, Rudra S, Packiam VT, Koshy M, Weichselbaum RR, Becker YT, Bodzin AS, Eggener SE. Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis. J Natl Cancer Inst. 2020 08 01; 112(8):847-854. PMID: 31728517; PMCID: PMC8453608.
      Citations: 13     Fields:    Translation:Humans
    30. Solanki AA, Savir-Baruch B, Liauw SL, Michalski J, Tward JD, Vapiwala N, Teoh EJ, LOCATE study group. 18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):354-362. PMID: 32464368.
      Citations: 2     Fields:    Translation:Humans
    31. Gutiontov SI, Choe KS, Miller JL, Liauw SL. Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression. Cancer Med. 2020 07; 9(13):4667-4675. PMID: 32400122; PMCID: PMC7333841.
      Citations: 5     Fields:    Translation:Humans
    32. Korpics MC, Rokni M, Degnan M, Aydogan B, Liauw SL, Redler G. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments. J Appl Clin Med Phys. 2020 Mar; 21(3):184-191. PMID: 31981305; PMCID: PMC7075383.
      Citations: 7     Fields:    Translation:Humans
    33. Turchan WT, Kauffmann G, Patel P, Oto A, Liauw SL. PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapy. Urol Oncol. 2020 06; 38(6):600.e1-600.e8. PMID: 31953005.
      Citations: 9     Fields:    Translation:Humans
    34. Solanki AA, Liauw SL. The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer. Transl Androl Urol. 2019 Dec; 8(Suppl 5):S533-S537. PMID: 32042640; PMCID: PMC6989851.
      Citations: 1     
    35. Stephenson A, Eggener SE, Bass EB, Chelnick DM, Daneshmand S, Feldman D, Gilligan T, Karam JA, Leibovich B, Liauw SL, Masterson TA, Meeks JJ, Pierorazio PM, Sharma R, Sheinfeld J. Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. J Urol. 2019 08; 202(2):272-281. PMID: 31059667.
      Citations: 63     Fields:    Translation:Humans
    36. Kapoor R, Deek MP, McIntyre R, Raman N, Kummerlowe M, Chen I, Gaver M, Wang H, Denmeade S, Lotan T, Paller C, Markowski M, Carducci M, Eisenberger M, Beer TM, Song DY, DeWeese TL, Hearn JW, Greco S, DeVille C, Desai NB, Heath EI, Liauw S, Spratt DE, Hung AY, Antonarakis ES, Tran PT. A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA). BMC Cancer. 2019 Jun 13; 19(1):572. PMID: 31196032; PMCID: PMC6567492.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    37. Akthar AS, Liao C, Eggener SE, Liauw SL. Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy. Eur Urol. 2019 11; 76(5):686-692. PMID: 31113644.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    38. Reddy AV, Golden DW, Brower JV, Liauw SL. Regional Influence of Radiation Oncology Residency Training on Job Securement over Two Time Periods. Cureus. 2019 Apr 18; 11(4):e4495. PMID: 31259113; PMCID: PMC6581416.
      Citations:    
    39. Foster B, Jackson W, Foster C, Dess R, Abu-Isa E, McLaughlin PW, Merrick G, Hearn J, Spratt D, Liauw S, Hamstra D. Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization. Am J Clin Oncol. 2019 04; 42(4):382-390. PMID: 30724780.
      Citations: 1     Fields:    Translation:Humans
    40. Jothishankar B, Almazan T, Kim Y, Liauw S, Abdulla F, Smith S, Kline J. Romidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sézary syndrome. Br J Haematol. 2019 07; 186(2):377-379. PMID: 30937886.
      Citations: 2     Fields:    Translation:Humans
    41. Reddy AV, Mills MN, Liauw SL, Baliga S, Kersh CR. Long term control and preservation of renal function after multiple courses of stereotactic body radiation therapy for renal cell carcinoma. Can J Urol. 2019 04; 26(2):9743-9745. PMID: 31012841.
      Citations:    Fields:    Translation:Humans
    42. Leng J, Akthar AS, Szmulewitz RZ, O'Donnell PH, Sweis RF, Pitroda SP, Smith N, Steinberg GD, Liauw SL. Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma. Clin Genitourin Cancer. 2019 Feb; 17(1):e12-e18. PMID: 30392939.
      Citations: 2     Fields:    Translation:Humans
    43. Kauffmann G, Arif F, Patel P, Oto A, Liauw SL. Pretreatment multiparametric MRI is independently associated with biochemical outcome in men treated with radiation therapy for prostate cancer. Urol Oncol. 2018 10; 36(10):471.e11-471.e18. PMID: 30122344.
      Citations: 4     Fields:    Translation:Humans
    44. Son CH, Liauw SL, Hasan Y, Solanki AA. Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):304-313. PMID: 29908944.
      Citations: 7     Fields:    Translation:Humans
    45. Foster CC, Lee AY, Furtado LV, Hart J, Alpert L, Xiao SY, Hyman NH, Sharma MR, Liauw SL. Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy. PLoS One. 2018; 13(7):e0200400. PMID: 29975772; PMCID: PMC6033459.
      Citations:    Fields:    
    46. Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA. Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features. JAMA Oncol. 2018 05 10; 4(5):e175230. PMID: 29372236; PMCID: PMC5885162.
      Citations: 31     Fields:    Translation:Humans
    47. Akthar AS, Wong AC, Parekh AD, Hubert G, Son CH, Pelizzari CA, Liauw SL. Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines. Adv Radiat Oncol. 2018 Jul-Sep; 3(3):339-345. PMID: 30202803; PMCID: PMC6128032.
      Citations: 5     
    48. Foster CC, Lee AY, Furtado LV, Hart J, Alpert L, Xiao SY, Hyman NH, Sharma MR, Liauw SL. Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy. PLoS One. 2018; 13(3):e0194234. PMID: 29522569; PMCID: PMC5844568.
      Citations: 4     Fields:    Translation:Humans
    49. Weiner AB, Matulewicz RS, Schaeffer EM, Liauw SL, Feinglass JM, Eggener SE. Contemporary management of men with high-risk localized prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2017 12; 20(4):442. PMID: 29125150.
      Citations: 5     Fields:    
    50. Apisarnthanarax S, Jabbour SK, Liauw SL, Murphy JD, Olsen JR, Chang DT. Gastrointestinal Cancers: Timing Is Everything. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1051-1058. PMID: 29165271; PMCID: PMC10910571.
      Citations:    Fields:    Translation:Humans
    51. Ying J, Wang CJ, Yan J, Liauw SL, Straka C, Pistenmaa D, Xie XJ, Lotan Y, Roehrborn C, Kim DN. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy. Am J Clin Oncol. 2017 Dec; 40(6):612-620. PMID: 26165416.
      Citations: 7     Fields:    Translation:Humans
    52. Ramey SJ, Agrawal S, Abramowitz MC, Moghanaki D, Pisansky TM, Efstathiou JA, Michalski JM, Spratt DE, Hearn JWD, Koontz BF, Liauw SL, Pollack A, Anscher MS, Den RB, Stephans KL, Zietman AL, Lee WR, Stephenson AJ, Tendulkar RD. Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer. Eur Urol. 2018 07; 74(1):99-106. PMID: 29128208.
      Citations: 15     Fields:    Translation:Humans
    53. Rodriguez JF, Liauw SL, Eggener SE. Managing Cancer Relapse After Radical Prostatectomy: Adjuvant Versus Salvage Radiation Therapy. Urol Clin North Am. 2017 Nov; 44(4):597-609. PMID: 29107276.
      Citations:    Fields:    Translation:Humans
    54. Clements MB, Schmidt KM, Canfield SE, Gilbert SM, Khandelwal SR, Koontz BF, Lallas CD, Liauw S, Nguyen PL, Showalter TN, Trabulsi EJ, Cathro HP, Schenkman NS, Krupski TL. Creation of a Novel Digital Rectal Examination Evaluation Instrument to Teach and Assess Prostate Examination Proficiency. J Surg Educ. 2018 Mar - Apr; 75(2):434-441. PMID: 28923535.
      Citations: 2     Fields:    Translation:Humans
    55. Liauw SL. A Pancreatic Predicament. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):296-297. PMID: 28871973.
      Citations:    Fields:    Translation:Humans
    56. Hamstra DA, Feng FY, Liauw SL, Son CH. High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir =0.2 to Select Men for Short-term Hormonal Therapy. Am J Clin Oncol. 2017 Aug; 40(4):348-352. PMID: 25436827.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    57. Kauffmann G, Liauw SL. The use of Hormonal Therapy to Augment Radiation Therapy in Prostate Cancer: An Update. Curr Urol Rep. 2017 Jul; 18(7):50. PMID: 28589396.
      Citations: 2     Fields:    Translation:Humans
    58. Weiner AB, Matulewicz RS, Schaeffer EM, Liauw SL, Feinglass JM, Eggener SE. Contemporary management of men with high-risk localized prostate cancer in the United States. Prostate Cancer Prostatic Dis. 2017 09; 20(3):283-288. PMID: 28631720.
      Citations: 11     Fields:    Translation:Humans
    59. Brower JV, Liauw SL, Reddy AV, Golden DW. Radiation oncology residency selection: A postgraduate evaluation of factor importance and survey of variables associated with job securement. Pract Radiat Oncol. 2017 Nov - Dec; 7(6):425-432. PMID: 28666900; PMCID: PMC5658268.
      Citations: 10     Fields:    Translation:Humans
    60. Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):437-454. PMID: 29114613; PMCID: PMC5605284.
      Citations: 10     
    61. Liss AL, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, Movsas B, Prestidge BR, Showalter TN, Taira AV, Vapiwala N, Davis BJ, Expert Panel on Radiation OncologyProstate, McLaughlin PW. ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer. Am J Clin Oncol. 2017 02; 40(1):1-10. PMID: 28059930.
      Citations: 3     Fields:    Translation:Humans
    62. Davis BJ, Taira AV, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Showalter TN, Vapiwala N. ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer. Brachytherapy. 2017 Mar - Apr; 16(2):266-276. PMID: 27964905.
      Citations: 6     Fields:    Translation:Humans
    63. Reddy AV, Christodouleas JP, Wu T, Smith ND, Steinberg GD, Liauw SL. External Validation and Optimization of International Consensus Clinical Target Volumes for Adjuvant Radiation Therapy in Bladder Cancer. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):740-746. PMID: 28244409.
      Citations:    Fields:    Translation:HumansPHPublic Health
    64. Expert Panel on Radiation Oncology-Prostate:, Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):62-84. PMID: 28740916; PMCID: PMC5514238.
      Citations: 10     
    65. Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, Hamstra DA, Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. J Clin Oncol. 2016 Oct 20; 34(30):3648-3654. PMID: 27528718.
      Citations: 120     Fields:    
    66. Lee AY, Golden DW, Bazan JG, Kopec M, Pelizzari CA, Aggarwal S, Chang DT, Liauw SL. Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):306-312. PMID: 28068238.
      Citations: 11     Fields:    Translation:Humans
    67. Pisansky TM, Agrawal S, Hamstra DA, Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ, Tendulkar RD. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):1046-1053. PMID: 27745980.
      Citations: 22     Fields:    Translation:Humans
    68. Apisarnthanarax S, Chia-Hsien Cheng J, Jabbour SK, Liauw SL, Murphy JD, Chang DT. Gastrointestinal Cancers-Changing the Standard for Rectal Cancer and Establishing a New Standard for Liver Tumors. Int J Radiat Oncol Biol Phys. 2016 07 01; 95(3):930-6. PMID: 27302509; PMCID: PMC10905611.
      Citations:    Fields:    Translation:Humans
    69. Liauw SL, Reddy AV, Weichselbaum RR, Smith ND, Steinberg GD. In Reply to Zaghloul. Int J Radiat Oncol Biol Phys. 2016 06 01; 95(2):855. PMID: 27131088.
      Citations:    Fields:    
    70. Liauw SL, Kropp LM, Dess RT, Oto A. Endorectal MRI for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions. Urol Oncol. 2016 09; 34(9):416.e15-21. PMID: 27241167.
      Citations: 7     Fields:    Translation:Humans
    71. Gunther JR, Liauw SL, Choi S, Mohamed AS, Thaker NG, Fuller CD, Stepaniak CJ, Das P, Golden DW. A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation. J Am Coll Radiol. 2016 Jul; 13(7):835-841.e1. PMID: 27210232; PMCID: PMC4935569.
      Citations: 6     Fields:    Translation:Humans
    72. Vikram R, Beland MD, Blaufox MD, Moreno CC, Gore JL, Harvin HJ, Heilbrun ME, Liauw SL, Nguyen PL, Nikolaidis P, Preminger GM, Purysko AS, Raman SS, Taffel MT, Wang ZJ, Weinfeld RM, Remer EM, Lockhart ME. ACR Appropriateness Criteria Renal Cell Carcinoma Staging. J Am Coll Radiol. 2016 May; 13(5):518-25. PMID: 27016804.
      Citations: 12     Fields:    Translation:Humans
    73. Son CH, Melotek JM, Liao C, Hubert G, Pelizzari CA, Eggener SE, Liauw SL. Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):e179-e185. PMID: 26961716.
      Citations: 3     Fields:    Translation:Humans
    74. Reddy AV, Pariser JJ, Pearce SM, Weichselbaum RR, Smith ND, Steinberg GD, Liauw SL. Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Apr 01; 94(5):1031-9. PMID: 27026309.
      Citations: 10     Fields:    Translation:Humans
    75. Chang DT, Jabbour SK, Brunner T, Cheng JC, Liauw SL, Meyer J, Wo J. Key New Studies in Gastric and Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):475-81. PMID: 26460987; PMCID: PMC10905609.
      Citations:    Fields:    
    76. Melotek JM, Liao C, Liauw SL. Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual Outcomes. PLoS One. 2015; 10(10):e0141639. PMID: 26512986; PMCID: PMC4626108.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    77. Pearce SM, Liauw SL, Eggener SE. Management of Low-Stage Testicular Seminoma. Urol Clin North Am. 2015 Aug; 42(3):287-98. PMID: 26216816.
      Citations: 4     Fields:    Translation:Humans
    78. Chang DT, Brunner T, Cheng JC, Liauw SL, Meyer J, Wo JY. Randomized trials and new directions in gastrointestinal cancer. Int J Radiat Oncol Biol Phys. 2015 Mar 01; 91(3):459-64. PMID: 25680590.
      Citations: 2     Fields:    
    79. Kumar KA, Wu T, Tonlaar N, Stepaniak C, Yenice KM, Liauw SL. Image-guided radiation therapy for prostate cancer: A computed tomography-based assessment of fiducial marker migration between placement and 7 days. Pract Radiat Oncol. 2015 Jul-Aug; 5(4):241-7. PMID: 25543198.
      Citations: 4     Fields:    Translation:Humans
    80. Son CH, Chennupati SK, Kunnavakkam R, Liauw SL. The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol. 2015 May-Jun; 5(3):e223-e228. PMID: 25491179.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    81. Chang DT, Brunner T, Cheng JC, Liauw S, Meyer J, Wo J. Oncology scan-novel treatment strategies for gastrointestinal cancers. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):699-703. PMID: 24969787.
      Citations: 2     Fields:    
    82. Corbin KS, Kindler HL, Liauw SL. Considering the role of radiation therapy for gastrointestinal stromal tumor. Onco Targets Ther. 2014; 7:713-8. PMID: 24872712; PMCID: PMC4026585.
      Citations: 13     
    83. Chennupati SK, Pelizzari CA, Kunnavakkam R, Liauw SL. Late toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy. Cancer Med. 2014 Aug; 3(4):954-61. PMID: 24803087; PMCID: PMC4303163.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    84. Song S, Hong JC, Minsky BD, Chang DT, Polite BN, Liauw SL, Tonlaar N. Combined-modality therapy for rectal cancer: analysis of potential differences in disease presentation, treatment adherence, and treatment outcome according to race. Am J Clin Oncol. 2014 Apr; 37(2):122-5. PMID: 23211225.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    85. Liu GF, Bair RJ, Bair E, Liauw SL, Koshy M. Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated versus three-dimensional conformal radiotherapy. PLoS One. 2014; 9(1):e82642. PMID: 24416146; PMCID: PMC3886968.
      Citations: 12     Fields:    Translation:Humans
    86. Golden DW, Corbin KS, Hasselle MD, Liauw SL, Stadler WM, Hahn OM, Weichselbaum RR, Salama JK, Ranck MC. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma. Am J Clin Oncol. 2013 Dec; 36(6):589-95. PMID: 22868242.
      Citations: 30     Fields:    Translation:HumansCTClinical Trials
    87. Solanki AA, Chang DT, Liauw SL. Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy. Onco Targets Ther. 2013; 6:1097-110. PMID: 23983475; PMCID: PMC3747849.
      Citations: 2     
    88. Solanki AA, Liauw SL. Tobacco use and external beam radiation therapy for prostate cancer: Influence on biochemical control and late toxicity. Cancer. 2013 Aug 01; 119(15):2807-14. PMID: 23633434.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    89. Macomber MW, Mullane KM, Liauw SL. Herpes zoster and radiation therapy: what radiation oncologists need to know about diagnosing, preventing, and treating herpes zoster. Pract Radiat Oncol. 2014 Jan-Feb; 4(1):58-64. PMID: 24621425.
      Citations: 3     Fields:    Translation:Humans
    90. Kalakota K, Liauw SL. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus. Urology. 2013 Jun; 81(6):1196-201. PMID: 23540863.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    91. Liauw SL, Connell PP, Weichselbaum RR. New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med. 2013 Feb 20; 5(173):173sr2. PMID: 23427246; PMCID: PMC3769139.
      Citations: 104     Fields:    Translation:Humans
    92. Choe KS, Liauw SL. Effects of aspirin on cancer initiation and progression. Expert Rev Anticancer Ther. 2013 Feb; 13(2):115-7. PMID: 23406550.
      Citations: 2     Fields:    Translation:Humans
    93. Semenenko VA, Tarima SS, Devisetty K, Pelizzari CA, Liauw SL. Validation of normal tissue complication probability predictions in individual patient: late rectal toxicity. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1103-9. PMID: 23021435.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    94. Golden DW, Novak CJ, Minsky BD, Liauw SL. Radiation dose =54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation. Radiat Oncol. 2012 Sep 13; 7:156. PMID: 22974515; PMCID: PMC3527337.
      Citations: 9     Fields:    Translation:Humans
    95. Lee AY, Wu T, Vannier MW, Testa G, Liauw SL. Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability. J Gastrointest Cancer. 2012 Sep; 43 Suppl 1:S202-7. PMID: 22492210.
      Citations:    Fields:    Translation:Humans
    96. Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012 Oct 01; 30(28):3540-4. PMID: 22927523; PMCID: PMC3454771.
      Citations: 48     Fields:    Translation:Humans
    97. Liauw SL, Pitroda SP, Eggener SE, Stadler WM, Pelizzari CA, Vannier MW, Oto A. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):378-84. PMID: 22717242.
      Citations: 32     Fields:    Translation:Humans
    98. Corbin KS, Kunnavakkam R, Eggener SE, Liauw SL. Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality of life. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):138-44. PMID: 24674317.
      Citations: 7     Fields:    
    99. Ali AN, Rossi PJ, Godette KD, Martin D, Liauw S, Vijayakumar S, Cooper S, Jani AB. Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):e1-e9. PMID: 24674267.
      Citations: 11     Fields:    
    100. Song S, Hong JC, McDonnell SE, Koong AC, Minsky BD, Chang DT, Liauw SL. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. Ann Surg Oncol. 2012 Aug; 19(8):2471-6. PMID: 22327251.
      Citations: 13     Fields:    Translation:Humans
    101. Edelman S, Liauw SL, Rossi PJ, Cooper S, Jani AB. High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1473-9. PMID: 22245201.
      Citations: 6     Fields:    Translation:Humans
    102. Song S, Yenice KM, Kopec M, Liauw SL. Image-guided radiotherapy using surgical clips as fiducial markers after prostatectomy: a report of total setup error, required PTV expansion, and dosimetric implications. Radiother Oncol. 2012 May; 103(2):270-4. PMID: 21890224.
      Citations: 12     Fields:    Translation:Humans
    103. Solanki AA, Liauw SL. Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer. Open Access J Urol. 2011 Jun 15; 3:95-104. PMID: 24198641; PMCID: PMC3818949.
      Citations: 1     
    104. Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):235-41. PMID: 21163587.
      Citations: 38     Fields:    Translation:HumansPHPublic Health
    105. Terakedis BE, Rossi PJ, Liauw SL, Johnstone PA, Jani AB. A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age. Am J Clin Oncol. 2010 Dec; 33(6):619-23. PMID: 20051808.
      Citations: 4     Fields:    Translation:Humans
    106. Liauw SL, Liauw SH. Prolongation of total treatment time because of infrequently missed days of treatment is not associated with inferior biochemical outcome after dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):751-7. PMID: 20932666.
      Citations: 6     Fields:    Translation:Humans
    107. Choe KS, Liauw SL. Radiotherapeutic strategies in the management of low-risk prostate cancer. ScientificWorldJournal. 2010 Sep 14; 10:1854-69. PMID: 20852828; PMCID: PMC5763745.
      Citations: 5     Fields:    Translation:Humans
    108. Malik R, Jani AB, Liauw SL. External beam radiotherapy for prostate cancer: urinary outcomes for men with high International Prostate Symptom Scores (IPSS). Int J Radiat Oncol Biol Phys. 2011 Jul 15; 80(4):1080-6. PMID: 20643513.
      Citations: 20     Fields:    Translation:Humans
    109. Gutt R, Liauw SL, Weichselbaum RR. The role of radiotherapy in locally advanced pancreatic carcinoma. Nat Rev Gastroenterol Hepatol. 2010 Aug; 7(8):437-47. PMID: 20628346.
      Citations: 19     Fields:    Translation:Humans
    110. Malik R, Jani AB, Liauw SL. Prostate-specific antigen halving time while on neoadjuvant androgen deprivation therapy is associated with biochemical control in men treated with radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1022-8. PMID: 20510547.
      Citations: 3     Fields:    Translation:Humans
    111. Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol. 2010 Jun 01; 28(16):2653-9. PMID: 20421534.
      Citations: 75     Fields:    Translation:Humans
    112. Choe KS, Correa D, Jani AB, Liauw SL. The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy. Cancer. 2010 Apr 01; 116(7):1820-6. PMID: 20143436.
      Citations: 17     Fields:    Translation:Humans
    113. Jani AB, Johnstone PA, Liauw SL, Master VA, Rossi PJ. Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis. Am J Clin Oncol. 2010 Apr; 33(2):168-72. PMID: 19745696.
      Citations: 9     Fields:    Translation:Humans
    114. Devisetty K, Zorn KC, Katz MH, Jani AB, Liauw SL. External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity. Int J Radiat Oncol Biol Phys. 2010 Jul 15; 77(4):1060-5. PMID: 20045267.
      Citations: 15     Fields:    Translation:Humans
    115. Kalakota K, Rakhno E, Pelizzari CA, Jani AB, Liauw SL. Late rectal toxicity after prostate brachytherapy: influence of supplemental external beam radiation on dose-volume histogram analysis. Brachytherapy. 2010 Apr-Jun; 9(2):131-6. PMID: 19853533.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    116. Liauw SL, Stadler WM, Correa D, Weichselbaum RR, Jani AB. Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy. Int J Radiat Oncol Biol Phys. 2010 May 01; 77(1):125-30. PMID: 19695789; PMCID: PMC3049990.
      Citations: 4     Fields:    Translation:Humans
    117. Liauw SL, Weichselbaum RR, Rash C, Correa D, Al-Hallaq HA, Pelizzari CA, Jani AB. Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer. Technol Cancer Res Treat. 2009 Jun; 8(3):201-6. PMID: 19445537.
      Citations: 6     Fields:    Translation:Humans
    118. Choe KS, Jani AB, Liauw SL. External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity? Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):755-60. PMID: 19464123.
      Citations: 34     Fields:    Translation:Humans
    119. Liauw SL, Fricano J, Correa D, Weichselbaum RR, Jani AB. Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores. Cancer. 2009 Apr 15; 115(8):1784-90. PMID: 19208426.
      Citations: 4     Fields:    Translation:Humans
    120. Gutt R, Liauw SL, Weichselbaum RR. Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? Nat Clin Pract Gastroenterol Hepatol. 2009 Jan; 6(1):38-46. PMID: 19029997.
      Citations: 4     Fields:    Translation:Humans
    121. Jani AB, Johnstone PA, Liauw SL, Master VA, Brawley OW. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis. Am J Clin Oncol. 2008 Aug; 31(4):375-8. PMID: 18845997.
      Citations: 18     Fields:    Translation:Humans
    122. Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin LL, DeWeese TL, Scardino PT, Stephenson AJ, Pollack A. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology. 2008 Dec; 72(6):1298-302; discussion 1302-4. PMID: 18672274; PMCID: PMC4020432.
      Citations: 31     Fields:    Translation:Humans
    123. Yeung AR, Liauw SL, Amdur RJ, Mancuso AA, Hinerman RW, Morris CG, Villaret DB, Werning JW, Mendenhall WM. Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? Cancer. 2008 Mar 01; 112(5):1076-82. PMID: 18186495.
      Citations: 6     Fields:    Translation:Humans
    124. Liauw SL, Minsky BD. The use of capecitabine in the combined-modality therapy for rectal cancer. Clin Colorectal Cancer. 2008 Mar; 7(2):99-104. PMID: 18501068.
      Citations: 1     Fields:    Translation:Humans
    125. Liauw SL, Weichselbaum RR, Zagaja GP, Jani AB. Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease? Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1316-21. PMID: 18234446.
      Citations: 2     Fields:    Translation:Humans
    126. Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol. 2007 Oct 10; 25(29):4581-6. PMID: 17925552.
      Citations: 79     Fields:    Translation:Humans
    127. Liauw SL, Amdur RJ, Morris CG, Werning JW, Villaret DB, Mendenhall WM. Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: salvage in the dissected or undissected neck. Head Neck. 2007 Aug; 29(8):715-9. PMID: 17274056.
      Citations: 7     Fields:    Translation:Humans
    128. Jani AB, Liauw SL, Blend MJ. The role of indium-111 radioimmunoscintigraphy in post-radical retropubic prostatectomy management of prostate cancer patients. Clin Med Res. 2007 Jun; 5(2):123-31. PMID: 17607048; PMCID: PMC1905929.
      Citations: 1     Fields:    Translation:Humans
    129. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007 May 20; 25(15):2035-41. PMID: 17513807; PMCID: PMC2670394.
      Citations: 269     Fields:    Translation:Humans
    130. Jani AB, Master VA, Rossi PJ, Liauw SL, Johnstone PA. Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry. Prostate Cancer Prostatic Dis. 2007; 10(4):347-51. PMID: 17505529.
      Citations: 5     Fields:    Translation:Humans
    131. Liauw SL, Mancuso AA, Morris CG, Amdur RJ, Mendenhall WM. Definitive radiotherapy for head-and-neck cancer with radiographically positive retropharyngeal nodes: incomplete radiographic response does not necessarily indicate failure. Int J Radiat Oncol Biol Phys. 2006 Nov 15; 66(4):1017-21. PMID: 17145530.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    132. Liauw SL, Byer JE, Yachnis AT, Amdur RJ, Mendenhall WM. Radiotherapy after subtotally resected or recurrent ganglioglioma. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):244-7. PMID: 17045420.
      Citations: 14     Fields:    Translation:Humans
    133. Liauw SL, Yeh AM, Morris CG, Olivier KR, Mendenhall NP. Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation. Int J Radiat Oncol Biol Phys. 2006 Dec 01; 66(5):1440-5. PMID: 16997504.
      Citations:    Fields:    Translation:Humans
    134. Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):669-73. PMID: 16887293.
      Citations: 38     Fields:    Translation:Humans
    135. Liauw SL, Mancuso AA, Amdur RJ, Morris CG, Villaret DB, Werning JW, Mendenhall WM. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol. 2006 Mar 20; 24(9):1421-7. PMID: 16549836.
      Citations: 29     Fields:    Translation:Humans
    136. Liauw SL, Amdur RJ, Mendenhall WM, Palta J, Kim S. The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer. Am J Clin Oncol. 2005 Oct; 28(5):456-9. PMID: 16199983.
      Citations: 7     Fields:    Translation:Humans
    137. Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, Klein EA, Kupelian PA, Roehrborn CG, Pistenmaa DA, Pacholke HD, Liauw SL, Katz MS, Leibel SA, Scardino PT, Slawin KM. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA. 2004 Mar 17; 291(11):1325-32. PMID: 15026399.
      Citations: 135     Fields:    Translation:Humans
    138. Liauw SL, Benda RK, Morris CG, Mendenhall NP. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. Cancer. 2004 Mar 01; 100(5):920-8. PMID: 14983486.
      Citations: 14     Fields:    Translation:Humans
    139. Liauw SL, Webster WS, Pistenmaa DA, Roehrborn CG. Salvage radiotherapy for biochemical failure of radical prostatectomy: a single-institution experience. Urology. 2003 Jun; 61(6):1204-10. PMID: 12809898.
      Citations: 17     Fields:    Translation:Humans
    Liauw's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (302)
    Explore
    _
    Co-Authors (45)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _